nicaraven has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, S; Guo, CY; Kawabata, T; Li, TS; Liu, KX; Moriwaki, T; Zhang, X | 1 |
| Goto, S; Li, TS; Luo, L; Urata, Y; Yan, C | 1 |
2 other study(ies) available for nicaraven and Lung Neoplasms
| Article | Year |
|---|---|
Nicaraven Attenuates Postoperative Systemic Inflammatory Responses-Induced Tumor Metastasis.
Topics: Animals; Cytokines; Inflammation; Lung; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Niacinamide; Reperfusion Injury; Surgical Procedures, Operative; Systemic Inflammatory Response Syndrome | 2020 |
Nicaraven reduces cancer metastasis to irradiated lungs by decreasing CCL8 and macrophage recruitment.
Topics: Amifostine; Animals; Antioxidants; Cell Line, Tumor; Chemokine CCL8; Gamma Rays; Humans; Lung; Lung Neoplasms; Macrophages; Mice, Inbred C57BL; Niacinamide; Radiation Tolerance; Radiation-Protective Agents | 2018 |